Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)

Q2 2019 13F Holders as of 6/30/2019

Type / Class: Equity / Common Stock
Shares outstanding: 27.1M
Number of holders: 20
Total 13F shares, excl. options: 1.88M
Shares change: +1.88M
Total reported value, excl. options: $17.7M
Value change: +$17.7M
Put/Call ratio: 0.34
Number of buys: 19
Price: $9.44

Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q2 2019

22 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q2 2019.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.88M shares of 27.1M outstanding shares and own 6.92% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (1M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (218K shares), Sumitomo Mitsui Trust Holdings, Inc. (130K shares), Nikko Asset Management Americas, Inc. (130K shares), ROYCE & ASSOCIATES LP (106K shares), Creative Planning (61K shares), MORGAN STANLEY (43.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (41.2K shares), Diametric Capital, LP (38.2K shares), and UNITED CAPITAL FINANCIAL ADVISERS, LLC (27.3K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.